. 2022 Jul 29;36(5):1669–1676. doi: 10.1111/jvim.16497

TABLE 1.

Clinical and clinicopathological data of control cats and cats with AKI and CKD

	Control cats median (range)	Novel AKI cats median (range)	AoC‐AKI cats median (range)	CKD cats median (range)
Age (y)	7.6 (0.6‐13.8) n = 15	6.3 (1.0‐14.0)¹ n = 22	8.0 (1.20‐16.0) n = 13	11.0 (4.8‐18.5)¹ n = 19
Bodyweight (kg)	2.8 (1.7‐5.0) n = 10	4.3 (3.8‐6.1) n = 6	4.6 (2.6‐5.6) n = 9	4.4 (2.7‐5.9) n = 9
Creatinine (mg/dL)	1.17 (0.80‐1.55)^1,2,3 n = 15	5.17 (1.73‐20.20)¹ n = 22	3.99 (2.31‐18.39)² n = 13	2.52 (1.79‐12.76)³ n = 19
USG	1.043 (1.035‐1.050)^1,2,3 n = 15	1.023 (1.010‐1.050)¹ n = 20	1.015 (1.010‐1.030)² n = 13	1.019 (1.008‐1.029)³ n = 19
SDMA (μg/dL)	11 (8‐21)^1,2,3 n = 15	36 (9‐170)¹ n = 22	33 (20‐75)^2,4 n = 13	19 (12‐69)^3,4 n = 19

Control cats median (range)

Novel AKI cats median (range)

AoC‐AKI cats median (range)

CKD cats median (range)

Age (y)

7.6 (0.6‐13.8)

n = 15

6.3 (1.0‐14.0)¹

n = 22

8.0 (1.20‐16.0)

n = 13

11.0 (4.8‐18.5)¹

n = 19

Bodyweight (kg)

2.8 (1.7‐5.0)

n = 10

4.3 (3.8‐6.1)

n = 6

4.6 (2.6‐5.6)

n = 9

4.4 (2.7‐5.9)

n = 9

Creatinine (mg/dL)

1.17 (0.80‐1.55)^1,2,3

n = 15

5.17 (1.73‐20.20)¹

n = 22

3.99 (2.31‐18.39)²

n = 13

2.52 (1.79‐12.76)³

n = 19

USG

1.043 (1.035‐1.050)^1,2,3

n = 15

1.023 (1.010‐1.050)¹

n = 20

1.015 (1.010‐1.030)²

n = 13

1.019 (1.008‐1.029)³

n = 19

SDMA (μg/dL)

11 (8‐21)^1,2,3

n = 15

36 (9‐170)¹

n = 22

33 (20‐75)^2,4

n = 13

19 (12‐69)^3,4

n = 19

Note: Kruskal‐Wallis test with post hoc Dunn's test for multiple comparisons was performed. Values with same superscript numbers are significantly different to one another.

Abbreviations: AKI, acute kidney injury; AoC, acute on chronic acute kidney injury; CKD, chronic kidney disease; SDMA, serum symmetric dimethylarginine; USG, urine specific gravity.